Citigroup Inc Sop Hi A Genetics Sa Transaction History
Citigroup Inc
- $190 Billion
- Q1 2025
A detailed history of Citigroup Inc transactions in Sop Hi A Genetics Sa stock. As of the latest transaction made, Citigroup Inc holds 68 shares of SOPH stock, worth $195. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68
Previous 15
353.33%
Holding current value
$195
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SOPH
# of Institutions
38Shares Held
25.5MCall Options Held
500Put Options Held
3.8K-
Ubs Asset Management Americas Inc Chicago, IL7.63MShares$21.9 Million0.01% of portfolio
-
Generation Investment Management LLP London, X06.79MShares$19.5 Million0.14% of portfolio
-
Chuck Akre Akre Capital Management LLC | Middleburg, Va2.24MShares$6.42 Million0.08% of portfolio
-
Banque Pictet & Cie Sa2.21MShares$6.35 Million0.06% of portfolio
-
Credit Suisse Ag Zurich, V82.17MShares$6.22 Million0.01% of portfolio
About SOPHiA GENETICS SA
- Ticker SOPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 64,153,700
- Market Cap $184M
- Description
- SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory...